Reversible agranulocytosis associated with oral terbinafine in a pediatric patient - 02/09/11
Doi : 10.1067/mjd.2001.117520
Abstract |
We report a case of terbinafine-induced agranulocytosis in a pediatric patient. This effect was noted 4 weeks after starting terbinafine and resolved within 1 week without the institution of therapy with granulocyte colony-stimulating factor, a course similar to reports in adults. With the incidence of severe side effects still unclear in children, this case argues for continued blood surveillance during courses of terbinafine and for the confirmation of infection before initiation of the drug. (J Am Acad Dermatol 2001;45:632-4.)
Le texte complet de cet article est disponible en PDF.Plan
 | Conflict of interest: None. |
| Reprints not available from authors. |
 | Published online July 18, 2001. |
© 2001
American Academy of Dermatology, Inc. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 45 - N° 4
P. 632-634 - octobre 2001 Retour au numéro
Article précédent
- Open pilot study on oxcarbazepine for the treatment of notalgia paresthetica
- Ekin Şavka, Okan Bolukbasib, Ali Akyolb, Göksun Karamana
- Hereditary benign intraepithelial dyskeratosis: Report of two cases with prominent oral lesions
- Camille A. Haisley-Royster, R.Rand Allingham, Gordon K. Klintworth, Neil S. Prose
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?